AW
DNLI icon

Avion Wealth’s Denali Therapeutics DNLI Stock Holding History

Avion Wealth’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
40
– – ﹤0.01% 1218
2026
Q1 		$0 Hold
40
– – ﹤0.01% 1321
2025
Q4 		$0 Hold
40
– – ﹤0.01% 1314
2025
Q3 		$0 Hold
40
– – ﹤0.01% 1273
2025
Q2 		$0 Buy
40
+15
+60% +$211 ﹤0.01% 1270
2025
Q1 		$0 Buy
+25
New +$479 ﹤0.01% 1099
2024
Q4 		– Sell
-25
Closed – – 1071
2024
Q3 		$0 Hold
25
– – ﹤0.01% 1085
2024
Q2 		$0 Buy
+25
New +$480 ﹤0.01% 996

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avion Wealth's DNLI Position: Q2 2026 in Review

Avion Wealth held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Avion Wealth first reported a position in DNLI in Q2 2024 and has held it in 8 quarters since. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Avion Wealth held 40 shares of Denali Therapeutics worth $1K as of Q2 2026.
  • Avion Wealth left its Denali Therapeutics share count unchanged in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1218 holding.
  • Avion Wealth first reported a position in Denali Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.